Editorial: Remembering the lost neuroscience of pharmaco-EEG

Acta Psychiatrica Scandinavica

Volumn 121, Issue 3, 2010, Pages 161-173

  Fink, Max ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMAZEPAM; BRONTIZALAM; CHLORPROMAZINE; DIETHAZINE; DOXEPIN; FLUTROLINE; IMIPRAMINE; MIANSERIN; MIRTAZAPINE; PHENYTOIN; PROCYCLIDINE; PSYCHOTROPIC AGENT; RESERPINE; SEDATIVE AGENT; TRIFLUBAZAM; UNCLASSIFIED DRUG;

ANXIETY DISORDER; CARDIOTOXICITY; CERTIFICATION; DEPRESSION; DRUG INDUSTRY; DYSTONIA; EDITORIAL; ELECTROCONVULSIVE THERAPY; ELECTRODE; ELECTROENCEPHALOGRAPHY; GRAND MAL EPILEPSY; HUMAN; MENTAL DISEASE; NERVOUS SYSTEM; NEUROSCIENCE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOSIS; PSYCHOTHERAPY; QUANTITATIVE ANALYSIS; RIGIDITY; SCHIZOPHRENIA; SEIZURE; SIDE EFFECT; TREMOR; WITHDRAWAL SYNDROME; BRAIN; DRUG EFFECT; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

BRAIN; ELECTROENCEPHALOGRAPHY; NEUROSCIENCES; PSYCHOTROPIC DRUGS;

EID: 76449096167     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2009.01467.x     Document Type: Editorial

References (70)

1. Brazier MAB. The effect of drugs on the electroencephalogram of man. Clin Pharmacol Ther 1964 5 : 102 116.
2. Shorter E, Healy D. Shock therapy: a history of electroconvulsive treatment in mental illness. New Brunswick NJ : Rutgers University Press, 2007.
3. Dukakis K, Tye L. Shock. the healing power of electroconvulsive therapy. New York : Penguin Group, 2006.
4. Fink M. Pharmaco-electroencephalography: A note on its history. Neuropsychobiology 1985 12 : 173 178.
5. Fink M. EEG and behavior: Association or dissociation in man? Integr Psychiatry 1993 9 : 108 123.
6. Fink M. A clinician-researcher and ECDEU: 1959-1980. In : Ban T, Healy D, Shorter E, eds. The triumph of psychopharmacology and the story of the CINP. Budapest : Animula, 2000 : 82 96.
7. Fink M Pharmaco-electroencephalography: a selective history of the study of brain responses to psychoactive drugs. In : Ban T, Shorter E, Healy D, eds. History of CINP, IV : 661 672, 2004.
8. Galderisi S, Sannita WG. Pharmaco-EEG: A history of progress and missed opportunity. Clin EEG Neurosci 2006 37 : 61 65.
9. Brazier MAB (ed Computer techniques in EEG analysis. EEG J 1961 13 (Suppl. 20 1 98.
10. Tarachow S, Fink M. A statistical study of a psychoanalytic hypothesis: Absence of a parent as a specific factor determining choice of neurosis. J Hillside Hosp 1953 2 : 67 71.
11. Fink M. Homosexuality with panic and paranoid states. J Hillside Hosp 1953 2 : 164 190.
12. Strauss H, Ostow M, Greenstein L. Diagnostic electroencephalography. New York : Grune & Stratton, 1952.
13. Fink M, Kahn RL. Relation of EEG delta activity to behavioral response in electroshock: Quantitative serial studies. Arch Neurol & Psychiatry 1957 78 : 516 525.
14. Fink M, Kahn RL, Green MA et al. Inhalant induced convulsions. Arch Gen Psychiatry 1961 4 : 259 266.
15. Fink M. Induced seizures as psychiatric therapy: Ladislas Meduna's contributions in modern neuroscience. JECT 2004 20 : 133 136.
16. Fink M. Convulsive therapy: theory and practice. NY : Raven Press, 1979.
17. Weinstein EA, Kahn RL. Denial of illness. Springfield IL : C. C Thomas, 1955.
18. Fink M, Itil TM Neurophysiology of the phantastica: EEG and behavioral relations in man. In : Efron D, Cole JO, Levine J, Wittenborn JR, eds. Psychopharmacology: A Review of Progress 1957-1967. Washington DC : US Govt Printing Office, 1968 : 1231 1239.
19. Fink M, Itil TM. EEG and human psychopharmacology: Clinical antidepressants. In : Efron D, Cole JO, Levine J, Wittenborn JR, eds. Psychopharmacology: A Review of Progress 1957-1967. Washington DC : US Govt Printing Office, 1968 : 671 682.
20. Itil TM, Fink M. EEG and behavioral aspects of the interaction of anticholinergic hallucinogens with centrally active compounds. In : Bradley P, Fink M, eds. Anticholinergic drugs and brain functions in animals and man. Amsterdam : Elsevier, 1968 : 149 168.
21. Fink M. Electroencephalographic and behavioral effects of Tofranil. Canad Psychiat Assoc J, 1959 4 (suppl 166 171.
22. Kramer JC, Klein DF, Fink M. Withdrawal symptoms following discontinuation of imipramine therapy. Am J Psychiatry 1961 118 : 549 550.
23. Kaempffert W Indian drugs for mental diseases. New York Times May 31, 1953, p. 1.
24. Wachspress M, Fink M, Blumberg AG, Miller JSA. Evaluation of high dose reserpine therapy for the relief of anxiety. J Hillside Hosp 1956 5 : 67 77.
25. Fink M, Shaw R, Gross G, Coleman FS. Comparative study of chlorpromazine and insulin coma in the therapy of psychosis. JAMA 1958 166 : 1846 1850.
26. Fink M. A Beautiful Mind and insulin coma: Social constraints on psychiatric diagnosis and treatment. Harv Rev Psychiatry 2003 11 : 284 290.
27. Doroshow DB. Performing a cure for schizophrenia: Insulin coma therapy on the wards. J Hist Med Allied Sci 2007 62 : 213 243.
28. Fink M, Klein DF, Kramer J. Clinical efficacy of chlorpromazine- procyclidine combination, imipramine and placebo in depressive disorders. Psychopharmacologia 1965 7 : 27 36.
29. Klein DF, Fink M. Psychiatric reaction patterns to imipramine. Am J Psychiatry 1962 119 : 432 438.
30. Klein DF, Fink M. Behavioral reaction patterns with phenothiazines. Arch Gen Psychiatry 1962 7 : 449 459.
31. Abrams R, Taylor MA. A comparison of unipolar and bipolar depressive illness. Am J Psychiatry 1980 137 : 1084.
32. Abrams R, Taylor MA. The importance of mood-incongruent psychotic symptoms in melancholia. J Affect Disord 1983 5 : 179 181.
33. Taylor MA, Abrams R. The phenomenology of mania: a new look at some old patients. Arch Gen Psychiatry 1973 29 : 520 222.
34. Taylor MA, Abrams R. Reassessing the bipolar-unipolar dichotomy. J Affect Disord 1980 2 : 195 217.
35. Klein DF. The pharmacological validation of psychiatric diagnosis. In : Robins LN, Barrett JE, eds. The validity of psychiatric diagnosis. New York : Raven Press, 1989 : 177 201.
36. Fink M, Taylor MA. Catatonia: a clinician's guide to diagnosis and treatment. Cambridge UK : Cambridge University Press, 2003.
37. Taylor MA, Fink M. Catatonia in psychiatric classification: A home of its own. Am J Psychiatry 2003 160 : 1233 1241.
38. Taylor MA, Fink M. Melancholia: the diagnosis, pathophysiology and treatment of depressive illness. Cambridge, UK : Cambridge University Press, 2006.
39. Taylor MA, Fink M. Restoring melancholia in the classification of mood disorders. Jrl Affective Disorders 2008 105 : 1 14.
40. Fink M, Taylor MA. The medical evidence-based model to identify psychiatric syndromes: Return to a classical paradigm. Acta Psychiatr Scand 2008 87 : 81 84.
41. Fink M. Experimental psychiatric research at Hillside: Review and prospect. J Hillside Hosp 1961 10 : 159 169.
42. Fink M. Effect of anticholinergic agent, diethazine, on EEG and behavior: Significance for theory of convulsive therapy. Arch Neurol Psychiatry 1958 80 : 380 387.
43. Fink M. Effects of anticholinergic compounds on post convulsive EEG and behavior of psychiatric patients. EEG clin Neurophysiol 1960 12 : 359 369.
44. Wikler A. Pharmacologic dissociation of behavior and EEG 'sleep patterns' in dogs: Morphine, n-allynormorphine and atropine. Proc Soc exp Biol 1952 79 : 261 264.
45. Wikler A. Clinical and electroencephalographic studies on the effect of mescaline, n-allyInormorphine and morphine in man. J Nerv Ment Dis 1954 120 : 157 175.
46. Bradley P, Fink M (eds). Anticholinergic drugs and brain functions in animals and man. Prog Brain Res 1968 28, 184.
47. Fink M. EEG classification of psychoactive compounds in man: Review and theory of behavioral association. In : Efron D, Cole JO, Levine J, Wittenborn JR, eds. Psychopharmacology: A Review of Progress 1957-1967. Washington, DC : U.S.G.P.O, 1968 : 497 507.
48. Fink M, Itil T. Neurophysiology of the phantastica: EEG and behavioral relations in man. In : Efron D, Cole JO, Levine J, Wittenborn JR, eds. Psychopharmacology: A Review of Progress 1957-1967. Washington, DC : U.S.G.P.O, 1968 : 1231 1239.
49. Fink M, Itil T. EEG and human psychopharmacology: IV: Clinical antidepressants. In : Efron D, Cole JO, Levine J, Wittenborn JR, eds. Psychopharmacology: A Review of Progress 1957-1967. Washington, DC : U.S.G.P.O, 1968 : 671 682.
50. Fink M. EEG and human psychopharmacology. Ann Rev Pharmacol 1969 9 : 241 258.
51. Fink M. EEG and human psychopharmacology Abstracts of proceedings of symposium at third World Congress of Psychiatry, Montreal, 1961) Electroenceph clin Neurophysiol 1963 15 : 133 137.
52. Simeon J, Spero M, Fink M. Clinical and EEG studies of doxepin. Psychosomatics 1969 10 : 14 17.
53. Itil TM, Polvan N, Hsu W. Clinical and EEG effects of GB-94, a tetracyclic antidepressant: EEG model in the discovery of a new psychotropic drug. Curr Ther Res 1972 14 : 395 413.
54. Pinder R, Fink M Mianserin. In : Lehmann H, ed. Non-MAOI and non-tricyclic antidepressants. Basel : S. Karger. Mod Probl Pharmacopsychiatry 1982 18 : 70 101.
55. Fink M, Irwin P. Pharmaco-EEG study of 6-azamianserin (ORG-3770): Dissociation of EEG and pharmacologic predictors of antidepressant activity. Psychopharmacology 1982 78 : 44 48.
56. Fink M, Irwin P. EEG and behavioral profile of flutroline (CP-36,584), a novel antipsychotic drug. Psychopharmacology 1981 72 : 67 71.
57. Fink M, Irwin P. CNS effects of acetylsalicylic acid (Aspirin). Clin Pharm Therap 1982 32 : 362 365.
58. Fink M, Irwin P, Sannita W, Papakostas Y, Green MA. Phenytoin: EEG effects and plasma levels in volunteers. Therap Drug Monitoring 1979 1 : 93 104.
59. Volavka J, Levine R, Feldstein S, Fink M. Short-term effects of heroin in man. Arch Gen Psychiatry 1974 30 : 677 684.
60. Volavka J, Fink M, Panayiotopoulos CP. Acute EEG effects of cannabis preparations in long-term users. In : Stefanis C, Dornbush R, Fink M, eds. Hashish - a study of long-term use. NY : Raven Press, 1977 : 1 181.
61. Itil TM, Cora R, Akpinar S, Herrmann WH, Patterson CJ. "Psychotropic" action of sex hormones: Computerized EEG in establishing the immediate CNS effects of steroid hormones. Curr Therapeutic Res 1974 16 : 1147 1170.
62. Stille G, Herrmann W, Bente D et al. Guidelines for pharmaco-EEG studies in man. Pharmacopsychiatry 1982 15 : 107 108.
63. Fink M, Kety S, McGaugh J (eds). Psychobiology of convulsive therapy. Washington DC : VH Winston & Sons, 1974.
64. American Psychiatric Association. Electroconvulsive therapy. Task Force Report #14. Washington, DC : American Psychiatric Association, 1978 : 200 pp.
65. Fink M, Abrams R, Bailine S, Jaffe R. Ambulatory electroconvulsive therapy. task force report of the association for convulsive therapy. Convulsive Ther. 1996 12 : 42 55.
66. Kellner CH, Knapp RG, Petrides G et al. Continuation ECT versus pharmacotherapy for relapse prevention in major depression: a multi-site study from CORE. Arch Gen Psychiatry 2006 63 : 1337 1344.
67. Petrides G, Fink M, Husain MM et al. ECT remission rates in psychotic versus non-psychotic depressed patients: A report from CORE. JECT 2001 17 : 244 253.
68. Fink M Electroshock: restoring the mind. NY : Oxford University Press, 1999 Re-issued as Electroshock: Healing Mental Illness, 2002.
69. Fink M. Electroconvulsive therapy: a guide for practitioners & their patients. 2nd edn. NY : Oxford University Press, 2009.
70. Fink M, Shorter E, Taylor MA Catatonia is not schizophrenia: Kraepelin's Error and the need to recognize catatonia as an independent syndrome in medical nomenclature. Schizophr Bull in press.